{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T05:35:44Z","timestamp":1791956144388,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.metabol.2006.01.008","type":"journal-article","created":{"date-parts":[[2006,5,19]],"date-time":"2006-05-19T07:19:02Z","timestamp":1148023142000},"page":"741-747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Effects of alendronate combined with hormone replacement therapy on osteoporotic postmenopausal Chinese women"],"prefix":"10.1016","volume":"55","author":[{"given":"Li-Nien","family":"Tseng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne Huey-Herng","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther Shih-Chu","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard Haw-Chang","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Chieh","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hung","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2006.01.008_bib1","doi-asserted-by":"crossref","first-page":"458","DOI":"10.7326\/0003-4819-126-6-199703150-00007","article-title":"The osteoporosis revolution","volume":"126","author":"Raisz","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.metabol.2006.01.008_bib2","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1093\/humrep\/15.10.2087","article-title":"Effects of alendronate and hormone replacement therapy, alone or in combination, on bone mass in postmenopausal women with osteoporosis: a prospective, randomized study","volume":"15","author":"Tiras","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.metabol.2006.01.008_bib3","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM199803123381107","article-title":"Treatment of postmenopausal osteoporosis","volume":"338","author":"Eastell","year":"1998","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"10.1016\/j.metabol.2006.01.008_bib4","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/BF01623000","article-title":"Bisphosphonate in osteoporosis: an introduction","volume":"3","author":"Fleisch","year":"1993","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.metabol.2006.01.008_bib5","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1056\/NEJM199310143291601","article-title":"The effect of postmenopausal estrogen therapy on bone density in elderly women","volume":"329","author":"Felson","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2006.01.008_bib6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s001980050283","article-title":"Identification of early postmenopausal women with no bone response to HRT: results of a five-year clinical trial","volume":"11","author":"Komulainen","year":"2000","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.metabol.2006.01.008_bib7","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2006.01.008_bib8","first-page":"265","article-title":"Dose-response relationships for alendronate treatment in osteoporotic elderly women","volume":"82","author":"Bone","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2006.01.008_bib9","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0002-9343(99)80134-X","article-title":"Alendronate treatment of the postmenopausal osteoporotic women: effect of multiple dosages on bone mass and bone remodeling","volume":"99","author":"Chesnut","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.metabol.2006.01.008_bib10","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2006.01.008_bib11","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1001\/archinte.1997.00440430099012","article-title":"Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial","volume":"157","author":"Ensrud","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.metabol.2006.01.008_bib12","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/jama.1997.03540380073035","article-title":"Prevention of nonvertebral fractures by alendronate: a meta-analysis","volume":"277","author":"Karf","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2006.01.008_bib13","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","article-title":"Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis","volume":"333","author":"Liberman","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2006.01.008_bib14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.7326\/0003-4819-128-4-199802150-00001","article-title":"Alendronate prevents postmenopausal bone loss in women without osteoporosis: a double-blind, randomized, controlled trial","volume":"128","author":"McClung","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.metabol.2006.01.008_bib15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0002-9343(99)80102-8","article-title":"A four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis","volume":"99","author":"Wimalawansa","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.metabol.2006.01.008_bib16","first-page":"3076","article-title":"Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: a randomized, controlled clinical trial","volume":"84","author":"Lindsay","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2006.01.008_bib17","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1210\/jcem.87.4.8323","article-title":"Effect of estrogen replacement plus low-dose alendronate treatment on bone density in surgically menopausal women with osteoporosis","volume":"87","author":"Palomba","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2006.01.008_bib18","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1001\/jama.289.19.2525","article-title":"Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: a randomized controlled trial","volume":"289","author":"Greenspan","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2006.01.008_bib19","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1210\/jc.2004-1091","volume":"90","author":"Greenspan","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl","key":"10.1016\/j.metabol.2006.01.008_bib20","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1007\/BF03194352","article-title":"Epidemiology of osteoporosis in Taiwan","volume":"7","author":"Tsai","year":"1997","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.metabol.2006.01.008_bib21","first-page":"209","article-title":"Hormone levels and menopausal status in middle-aged women: a cross-sectional study","volume":"18","author":"Chang","year":"1999","journal-title":"Chin J Public Health"},{"key":"10.1016\/j.metabol.2006.01.008_bib22","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s001980170011","article-title":"Raloxifene versus continuous combined estrogen\/progestin therapy: densitometric and biochemical effects in healthy postmenopausal Taiwanese women","volume":"12","author":"Tsai","year":"2001","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.metabol.2006.01.008_bib23","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM199802193380801","article-title":"Prevention of bone loss with alendronate in post-menopausal women under 60 years of age","volume":"338","author":"Hosking","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2006.01.008_bib24","first-page":"720","article-title":"Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate\/Estrogen Study Group","volume":"85","author":"Bone","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2006.01.008_bib25","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S8756-3282(00)00384-7","article-title":"Effects of alendronate on osteopenic postmenopausal Chinese women","volume":"27","author":"Yen","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.metabol.2006.01.008_bib26","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S8756-3282(00)00378-1","article-title":"Alendronate prevents bone loss in Chinese women with osteoporosis","volume":"27","author":"Lau","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.metabol.2006.01.008_bib27","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1210\/jcem.87.6.8575","article-title":"Alendronate increases bone mass and reduces bone markers in postmenopausal African-American women","volume":"87","author":"Bell","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2006.01.008_bib28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s001980050171","article-title":"Skeletal benefits of two years of alendronate treatment are similar for early postmenopausal Asian and Caucasian women","volume":"9","author":"Wasnich","year":"1999","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.metabol.2006.01.008_bib29","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1210\/jc.2003-030198","article-title":"Effects of alendronate and hormone replacement therapy, alone and in combination, on bone mass and markers of bone turnover in elderly women with osteoporosis","volume":"89","author":"Evio","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2006.01.008_bib30","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1210\/jcem.87.3.8325","article-title":"Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis","volume":"87","author":"Johnell","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2006.01.008_bib31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0002-9343(01)01124-X","article-title":"Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs","volume":"112","author":"Cummings","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.metabol.2006.01.008_bib32","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1373\/clinchem.2004.037424","article-title":"Assessment of urinary bone markers for monitoring treatment of osteoporosis","volume":"50","author":"Worsfold","year":"2004","journal-title":"Clin Chem"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604950600045X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604950600045X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:10:29Z","timestamp":1758424229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002604950600045X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S002604950600045X"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2006.01.008","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of alendronate combined with hormone replacement therapy on osteoporotic postmenopausal Chinese women","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2006.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}